Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Prograf approved for new indication in Japan, launched in France

April 26, 1996

Positive results reported in AllerVax Ragweed trials

April 26, 1996

Terramed receives patent protection for vaccine technology

April 19, 1996

CellCept available in Europe

April 19, 1996

Corixa in-licenses Optivax delivery system for vaccines

April 12, 1996

AllerVax codevelopment terminated by HMR

March 15, 1996

AI-502 slated to enter clinical trials

March 15, 1996

Axis Genetics reports on vaccine technology

March 15, 1996

T Cell Sciences, ArQule to collaborate on T cell modulators

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 15, 2025.
ASGCT 2025: Gene and cell therapies transform metabolic diseases
BioWorld Science
Metabolic disorders such as argininosuccinic and glutaric aciduria, methylmalonic acidemia, homocystinuria or primary hyperoxaluria require specific diets to...
Abbott studies show CGM users have fewer hospitalizations
BioWorld MedTech
A pair of studies published in Diabetologia demonstrate that use of continuous glucose monitors (CGMs) reduces hospitalizations in people with type 1 diabetes and...
Rznomics in $1.3B Lilly pact to make hearing loss RNA editor drug
BioWorld
Rznomics Inc. scored a potential ₩1.9 trillion (US$1.35 billion) global license option agreement with Eli Lilly and Co. to codevelop a novel RNA editing gene...